Silverback Therapeutics Company
Silverback Therapeutics is a biopharmaceutical company that develops ImmunoTAC therapies targeting previously inaccessible disease pathways. They are developing a new generation of systemically delivered, locally active therapies that potently modulate fundamental disease pathways once deemed inaccessible.
Industry:
Genomic and Epigenominc Instabillity
Headquarters:
United States
Register and Claim Ownership